D-0837-2020 Class II Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

FDA drug recall D-0837-2020 was initiated by Teva Pharmaceuticals USA on Jan 27, 2020 and is designated Class II. Reason for recall: CGMP deviations: Product bottle may be absent of desiccant. The recall status is terminated (terminated Nov 3, 2020). Affected quantity: 17,436 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 19, 2020
Initiation Date
Jan 27, 2020
Termination Date
Nov 3, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
17,436 bottles

Product description

Methylphenidate hydrochloride Extended-Release ablets USP (CII), 27 mg, 100-count bottle, Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 62037-734-01

Reason for recall

CGMP deviations: Product bottle may be absent of desiccant.

Distribution pattern

USA Nationwide

Code information

Lot # 1332799A, Exp 11/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0837-2020
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0837-2020. Report a data issue: hello@regdatalab.com.